CS logo
small CS logo
Center for Clinical Studies, University Hospital Regensburg

Regensburg, Germany
University hospital in Bavaria
Franz-Josef-Strauß-Allee 11, 93053 Regensburg

About Center for Clinical Studies, University Hospital Regensburg


"Das Universitätsklinikum Regensburg (UKR) ist ein Krankenhaus der höchsten Versorgungsstufe. Es bietet in 31 human- und zahnmedizinische Kliniken, Polikliniken, Instituten und Abteilungen fast das komplette medizinische Fächerspektrum an und verfügt über 839 Betten sowie 52 tagesklinische Behandlungsplätze. Ausgerichtet ist das Universitätsklinikum Regensburg auf Hochleistungsmedizin mit besonderem Fokus auf Transplantations- und Intensivmedizin sowie onkologische und kardiovaskuläre Erkrankungen. Bei der durchschnittlichen Fallschwere („Case-Mix-Index“) liegt das UKR mit an der Spitze der deutschen Universitätsklinika. Gemeinsames Ziel aller Mitarbeiter sind die optimale medizinische und pflegerische Versorgung der Patienten."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Center for Clinical Studies, University Hospital Regensburg


During the past decade, Center for Clinical Studies, University Hospital Regensburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Clinical Studies, University Hospital Regensburg" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Hospital of Navarra" with 1 trials as a collaborator, "Kantar Health" with 1 trials as a collaborator, "Medical University of Graz" with 1 trials as a collaborator and "National Taiwan University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

Clinical Trials Conditions at Center for Clinical Studies, University Hospital Regensburg


According to Clinical.Site data, the most researched conditions in "Center for Clinical Studies, University Hospital Regensburg" are "Lung Cancer" (2 trials), "Cancer" (1 trials) and "Quality of Life" (1 trials). Many other conditions were trialed in "Center for Clinical Studies, University Hospital Regensburg" in a lesser frequency.

Clinical Trials Intervention Types at Center for Clinical Studies, University Hospital Regensburg


Most popular intervention types in "Center for Clinical Studies, University Hospital Regensburg" are "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Immunotherapy" (1 trials), "Radiochemotherapy" (1 trials), "Surgery" (1 trials) and "Targeted therapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Center for Clinical Studies, University Hospital Regensburg


The vast majority of trials in "Center for Clinical Studies, University Hospital Regensburg" are 3 trials for "All" genders.

Clinical Trials Status at Center for Clinical Studies, University Hospital Regensburg


Currently, there are NaN active trials in "Center for Clinical Studies, University Hospital Regensburg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Center for Clinical Studies, University Hospital Regensburg, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Center for Clinical Studies, University Hospital Regensburg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".